We conducted a systematic review of literature and meta-analysis for the studies on local treatment modalities for breast cancer oligometastases (OM) to lung and liver. The objective of the current study was to report survival outcome following optimal local treatment for OM in breast cancer. This would help in baseline assumptions for survival estimates for future prospective trials as well as provide guidelines for patient counselling in clinical practice
Breast cancer liver metastases (BCLM) are not uncommon (about 18\% of cases): although some patients...
AbstractRecently, the state of oligometastases has been spotlighted in the treatment strategy for me...
Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity....
Aim: Oligometastatic breast cancer (OMBC) is a disease-entity with potential for long-term remission...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
Breast cancer (BC) is the most frequent cancer among women and represents the second leading cause o...
AbstractRecently, the state of oligometastases has been spotlighted in the treatment strategy for me...
Metastatic breast cancer represents an incurable condition, however, the increasing interest towards...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
Abstract: Breast cancer remains the most common cause of cancer death among women. Despite its consi...
BackgroundAn international retrospective cohort study was conducted to clarify the survival advantag...
Patients with oligometastatic breast cancer (BC) are candidates of choice for metastasis-directed th...
BACKGROUND: The concept of oligometastatic disease (OMD) has expanded the scope of potentially curat...
BACKGROUND: The concept of oligometastatic disease (OMD) has expanded the scope of potentially curat...
Breast cancer liver metastases (BCLM) are not uncommon (about 18\% of cases): although some patients...
Breast cancer liver metastases (BCLM) are not uncommon (about 18\% of cases): although some patients...
AbstractRecently, the state of oligometastases has been spotlighted in the treatment strategy for me...
Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity....
Aim: Oligometastatic breast cancer (OMBC) is a disease-entity with potential for long-term remission...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
Breast cancer (BC) is the most frequent cancer among women and represents the second leading cause o...
AbstractRecently, the state of oligometastases has been spotlighted in the treatment strategy for me...
Metastatic breast cancer represents an incurable condition, however, the increasing interest towards...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
Abstract: Breast cancer remains the most common cause of cancer death among women. Despite its consi...
BackgroundAn international retrospective cohort study was conducted to clarify the survival advantag...
Patients with oligometastatic breast cancer (BC) are candidates of choice for metastasis-directed th...
BACKGROUND: The concept of oligometastatic disease (OMD) has expanded the scope of potentially curat...
BACKGROUND: The concept of oligometastatic disease (OMD) has expanded the scope of potentially curat...
Breast cancer liver metastases (BCLM) are not uncommon (about 18\% of cases): although some patients...
Breast cancer liver metastases (BCLM) are not uncommon (about 18\% of cases): although some patients...
AbstractRecently, the state of oligometastases has been spotlighted in the treatment strategy for me...
Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity....